BIOMERICA INC (BMRA)
Nasdaq · In Vitro & In Vivo Diagnostic Substances · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for BIOMERICA INC. Most notable: 2026-08-26: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-12 | Chin Eric | director | A | 22,500 | 0 | $0 |
| 2025-12-12 | Lu Gary | officer | A | 40,000 | 0 | $0 |
| 2025-12-12 | Irani Zackary S. | director | A | 52,500 | 0 | $0 |
| 2025-12-12 | BARBIERI ALLEN | director | A | 30,000 | 0 | $0 |
| 2025-12-12 | Gary M. Huff | director | A | 20,000 | 0 | $0 |
| 2025-12-12 | MOATAZEDI DAVID | director | A | 20,000 | 0 | $0 |
| 2024-12-13 | Lu Gary | officer | A | 155,000 | 0.31 | $48,050 |
| 2024-12-13 | BARBIERI ALLEN | director | A | 110,000 | 0.31 | $34,100 |
| 2024-12-13 | Irani Zackary S. | director | A | 250,000 | 0.31 | $77,500 |
| 2024-12-13 | Emerson Jane | director | A | 85,000 | 0.31 | $26,350 |
| 2024-12-13 | MOATAZEDI DAVID | director | A | 85,000 | 0.31 | $26,350 |
| 2024-12-13 | Coste Catherine | director | A | 85,000 | 0.31 | $26,350 |
| 2024-01-02 | BARBIERI ALLEN | director | G | 15,000 | 0 | $0 |
| 2023-06-27 | BARBIERI ALLEN | director | G | 8,000 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.